RP
ELV icon

Raelipskie Partnership’s Elevance Health ELV Stock Holding History

Raelipskie Partnership’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.46K Hold
5
– – ﹤0.01% 111
2025
Q4 		$1.75K Hold
5
– – ﹤0.01% 107
2025
Q3 		$1.62K Hold
5
– – ﹤0.01% 107
2025
Q2 		$1.95K Hold
5
– – ﹤0.01% 108
2025
Q1 		$2.17K Hold
5
– – ﹤0.01% 110
2024
Q4 		$1.84K Sell
5
-45
-90% -$18.8K ﹤0.01% 110
2024
Q3 		$26K Buy
+50
New +$26.7K 0.01% 81

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Raelipskie Partnership's ELV Position: Q1 2026 in Review

Raelipskie Partnership held its Elevance Health (ELV) position steady in Q1 2026 at 5 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #111.

Raelipskie Partnership first reported a position in ELV in Q3 2024 and has held it in 7 quarters since. The position peaked at $26K in Q3 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Raelipskie Partnership held 5 shares of Elevance Health worth $1.46K as of Q1 2026.
  • Raelipskie Partnership left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up ﹤0.01% of Raelipskie Partnership's portfolio in Q1 2026, its #111 holding.
  • Raelipskie Partnership first reported a position in Elevance Health in Q3 2024 and has held it in 7 quarters since.
  • Raelipskie Partnership's Elevance Health position peaked at $26K in Q3 2024.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Raelipskie Partnership's 13F filing for Q1 2026, filed 29 Apr 2026.